Fiscal Period | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Period End Date | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
Net Income/ Starting Line | -22.85 | -9.69 | -14.20 | -14.20 |
Depreciation/ Depletion | 0.15 | 0.21 | 0.24 | 0.24 |
Non- Cash Items | 6.58 | 5.06 | 3.84 | 3.84 |
Changesin Working Capital | 27.02 | -37.70 | 44.21 | 44.21 |
Cashfrom Operating Activities | 10.89 | -42.12 | 34.08 | 34.08 |
Capital Expenditures | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Cash Flow Items Total | 0.46 | 0.53 | 0.91 | 0.91 |
Cashfrom Investing Activities | 0.46 | 0.53 | 0.91 | 0.91 |
Financing Cash Flow Items | -7.04 | -5.59 | -5.23 | -5.23 |
Issuance( Retirement)of Debt Net | -7.67 | 50.59 | -29.18 | -29.18 |
Cashfrom Financing Activities | -14.71 | 45.00 | -34.41 | -34.41 |
Net Changein Cash | -3.36 | 3.42 | 0.58 | 0.58 |
Cash Interest Paid | 7.04 | 5.59 | 4.74 | 4.74 |
Bharat Immunologicals & Biologicals Corporation Dividend Bharat Immunologicals & Biologicals Corporation Bonus Bharat Immunologicals & Biologicals Corporation News Bharat Immunologicals & Biologicals Corporation AGM Bharat Immunologicals & Biologicals Corporation Rights Bharat Immunologicals & Biologicals Corporation Splits Bharat Immunologicals & Biologicals Corporation Board Meetings Bharat Immunologicals & Biologicals Corporation Key Metrics Bharat Immunologicals & Biologicals Corporation Shareholdings Bharat Immunologicals & Biologicals Corporation Profit Loss Bharat Immunologicals & Biologicals Corporation Balance Sheet Bharat Immunologicals & Biologicals Corporation Q1 Results Bharat Immunologicals & Biologicals Corporation Q2 Results Bharat Immunologicals & Biologicals Corporation Q3 Results Bharat Immunologicals & Biologicals Corporation Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks